Biological Information
Background Information:
XIAP is a multifunctional regulator of programmed cell death and cell-survival pathways. It directly suppresses the catalytic activity of key executioner caspases eg. caspase-3 and caspase-7, by binding their active sites, and maintains caspase-9 in an inactive monomeric state, thereby potently blocking apoptosis at multiple points in the intrinsic and extrinsic death pathways. XIAP also acts as an E3 ubiquitin ligase, ubiquitinating a broad range of signalling proteins including RIPK1, CASP3/7/8/9, survivin (BIRC5) and others, which modulates not only apoptotic signalling but also NF-kappaB, MAPK and Wnt pathways, thereby affecting inflammation and proliferation. Over-expression has been validated in numerous types of cancer cells and has been linked to malignant transformation, increased proliferation and metastasis.
Target Class:
Ubiquitination-related
Family:
IAP
Sub Family:
E3 Ligase
Protein Name:
XIAP
Protein Aliases:
ILP 1; hILP ;IAP-3; hIAP-3; hIAP3; X-linked IAP
Accession Number:
NM_001167.3
UniProt Number:
P98170
Gene Name:
XIAP
Gene ID:
331
Gene Aliases:
API3; ILP1; MIHA; XLP2; BIRC4; IAP-3; hIAP3; hIAP-3
Target Species:
Human
Usage
Product Type:
Enzymes
Application:
Drug Discovery & Development
Storage Conditions:
1 year at -70°C
Usage disclaimer:
These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.
Assay Information
Assay Type:
Enzymatic
Assay Measures:
ECL
Bioassay Data
Trademark Statement:
For Research Use Only
Clinical Relevance
Therapeutic Area:
Oncology